Your browser is no longer supported. Please, upgrade your browser.
Settings
CODX Co-Diagnostics, Inc. daily Stock Chart
CODX [NASD]
Co-Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own44.41% Shs Outstand12.14M Perf Week-15.75%
Market Cap12.99M Forward P/E- EPS next Y- Insider Trans- Shs Float7.18M Perf Month-35.93%
Income-5.80M PEG- EPS next Q- Inst Own1.90% Short Float1.22% Perf Quarter-58.85%
Sales0.03M P/S409.95 EPS this Y-225.30% Inst Trans- Short Ratio1.40 Perf Half Y-68.89%
Book/sh0.01 P/B107.00 EPS next Y- ROA-184.00% Target Price- Perf Year-63.61%
Cash/sh0.18 P/C5.90 EPS next 5Y- ROE-299.40% 52W Range1.01 - 6.66 Perf YTD-28.19%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-83.93% Beta-
Dividend %- Quick Ratio1.10 Sales past 5Y- Gross Margin- 52W Low5.94% ATR0.21
Employees15 Current Ratio1.10 Sales Q/Q273.20% Oper. Margin- RSI (14)35.98 Volatility21.39% 17.22%
OptionableNo Debt/Eq19.00 EPS Q/Q59.90% Profit Margin- Rel Volume7.95 Prev Close1.17
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume62.42K Price1.07
Recom- SMA20-16.43% SMA50-40.52% SMA200-59.45% Volume496,152 Change-8.55%
Jan-15-19 03:34AM  Wall Street Club Release: CODX Spike Nearly 26% on 53x Avg Volume Following News of Presentation with LGC, Biosearch ACCESSWIRE -13.39%
Jan-10-19 06:30AM  Co-Diagnostics, Inc. to Present at PAG XXVII on January 14 in San Diego Business Wire
Dec-20-18 06:00AM  Co-Diagnostics Inc - End of Exciting Year, Revenues & More Excitement Ahead in 2019 ACCESSWIRE
Dec-14-18 06:30AM  Co-Diagnostics, Inc Expands Licensing Opportunities Internationally with Receipt of UK Patent for RapidProbe Technology Business Wire -7.20%
Dec-10-18 06:12AM  Co-Diagnostics Inc CEO Expects Revenue Before Year End & Predicts a Great 2019 ACCESSWIRE
Dec-04-18 07:19AM  Co-Diagnostics CEO Ike Egan: Excited about fourth quarter revenue and talking Sales Expectations & Other Milestones in Todays Virtual Investor Conference ACCESSWIRE +5.88%
Nov-30-18 01:43PM  Co-Diagnostics CEO to Discuss Progress and Forecasts in a Lytham Partners Virtual Investors Conference Presentation on Tuesday, December 4, 2018 at 4:00 pm ET Business Wire
Nov-27-18 07:16AM  Co-Diagnostics Inc CEO Discusses Revenue and Company Advancements with the Wall Street Club ACCESSWIRE +5.63%
Nov-26-18 06:30AM  Co-Diagnostics, Inc. to Conduct Product Training Seminars with Distributor and Customers in the Dominican Republic Business Wire
Nov-20-18 07:42AM  Co-Diagnostics CEO Records Exclusive Interview Discussing Progress, Momentum, and Future Ambitions ACCESSWIRE
Nov-14-18 08:15AM  Co-Diagnostics, Guardant Health, and Others Included in Health Care Stocks Snapshot ACCESSWIRE +12.22%
Nov-01-18 07:58AM  Co-Diagnostics, Inc. Signs First of Many License Agreements for its CoPrimer Technology ACCESSWIRE +6.93%
Oct-30-18 06:30AM  Co-Diagnostics, Inc. and LGC, Biosearch Technologies Sign License Agreement for CoPrimer Technology Business Wire
Oct-29-18 06:30AM  Co-Diagnostics, Inc. to Present at Utah Mosquito Abatement Association Conference Business Wire
Oct-23-18 07:17AM  World Health Organization & UNICEF Confirm High Demand for Zika Solutions in Co-Diagnostics Targeted Markets ACCESSWIRE
Oct-18-18 06:30AM  Co-Diagnostics, Inc. Receives CE Mark for Zika Screening Test Business Wire
Oct-16-18 07:00AM  Co-Diagnostics, Inc. to Expand Technology Licensing Model After Patent Issuance ACCESSWIRE +7.34%
Oct-10-18 06:30AM  Co-Diagnostics Receives Patent for CoPrimer Technology Business Wire
Sep-25-18 09:10AM  Co-Diagnostics, Inc. Offering its Primer Design Services to the Growing $7 Billion PCR Industry ACCESSWIRE
Sep-20-18 06:30AM  Co-Diagnostics, Inc. to Present at the Fourth Annual Robins Equity Research Roundup Business Wire
Sep-13-18 06:30AM  Co-Diagnostics Adds Central and South America to its List of International Target Markets Business Wire
Sep-11-18 09:00AM  Ground Breaking Co-Diagnostics' CoPrimers(TM) Technology Advances SNP Detection ACCESSWIRE
Aug-29-18 08:30AM  BDA International Release: Co-Diagnostics, Inc. Has A Real Growth Strategy And Is Planning Big For Its Diagnostics Technology ACCESSWIRE
Aug-21-18 06:30AM  Co-Diagnostics Announces Filing of S-3 Shelf Registration Business Wire
Aug-14-18 09:06AM  (CODX) BDA International Release: Fulfilment of Financing to Fast-Track Near Term Sales for Co-Diagnostics, Inc. ACCESSWIRE
Aug-10-18 06:30AM  Co-Diagnostics Announces Closing of Debt Financing Business Wire
Jul-31-18 07:00AM  Free Technical Research on Agilent Technologies and Three More Medical Research Equities ACCESSWIRE
Jul-25-18 11:30AM  Kivuto Launches Kivuto Cloud to Enhance Access to Adobe Creative Cloud Apps ACCESSWIRE
11:30AM  BDA International Release: Co-Diagnostics Inc.: CE Markers and Anticipated Future Growth ACCESSWIRE
06:30AM  Co-Diagnostics Receives CE Mark for Tuberculosis Test Kit Business Wire
Jul-17-18 06:30AM  Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test Business Wire +6.13%
Jun-11-18 06:30AM  Co-Diagnostics, Inc. to Host Booth at CARPHA Conference Business Wire
Jun-06-18 08:10AM  Today's Research Reports on Stocks to Watch: Co-Diagnostics and Valeant Pharmaceuticals ACCESSWIRE
Jun-05-18 06:30AM  Co-Diagnostics, Inc. Announces Advancement of Co-Primers Technology in Multiplex SNP Genotyping Business Wire +18.92%
Jun-04-18 08:10AM  Today's Research Reports on Stocks to Watch: Co-Diagnostics and Jaguar Health ACCESSWIRE -7.31%
08:05AM  Co-Diagnostics Shares Soar on Recent Developments, Technology Review ACCESSWIRE
Jun-01-18 06:30AM  Co-Diagnostics, Inc. Announces Participation in Research Project with Stanford University Business Wire +65.17%
Apr-16-18 06:30AM  Co-Diagnostics CEO to Discuss Strategic Direction in a Lytham Partners Virtual Presentation and Fireside Chat Event on Thursday, April 19, 2018 at 2:00 pm ET Business Wire
Apr-05-18 06:30AM  Co-Diagnostics Files Initial Annual Report on Form 10-K and Updates Corporate Developments Business Wire
Mar-22-18 06:30AM  Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing Facility in India Business Wire
Feb-28-18 06:30AM  Co-Diagnostics Inc Announces Positive Results from Co-Primers Technology in Multiplex Tests for SNP Detection Business Wire +10.90%
Feb-21-18 06:30AM  Co-Diagnostics, Inc. Ships Product to India for Validation Study Business Wire
Jan-30-18 06:30AM  Co-Diagnostics, Inc. Initiates Vector Control Program in Dominican Republic Business Wire
Dec-19-17 06:30AM  Co-Diagnostics, Inc. Enters Into Lease for New, Upgraded Laboratory Facility Business Wire
Dec-12-17 06:30AM  Co-Diagnostics, Inc. Announces Sale of Molecular Diagnostic Tests, Including Zika Virus, to Major Caribbean Laboratory Business Wire +6.18%
Nov-22-17 03:11PM  Co-Diagnostics, Inc. to Present at the Lytham Partners Virtual Investor Conference on November 30, 2017 at 2:00 p.m. ET Business Wire
Nov-21-17 04:49PM  How Does Co-Diagnostics Inc (CODX) Compare To The Healthcare Sector? Simply Wall St.
Nov-15-17 07:30AM  Co-Diagnostics, Inc. Reports Q3 Financial Results and Updates Corporate Developments Business Wire -6.85%
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.